TabsDetailsBasic DetailsDate: Tuesday, February 12, 2019Type: PublicationDescription: The purpose of this manuscript was to develop a flexible analytic tool for the Food and Drug Administration's (FDA's) Sentinel System to assess adherence to safe use recommendations with two capabilities: characterize adherence to patient monitoring recommendations for a drug, and characterize concomitant medication use before, during, and/or after drug therapy. The tool has two key capabilities: (a) characterize adherence to patient monitoring recommendations for a treatment; and (b) characterize concomitant medication use before, during, and/or after a drug therapy. Read More Materials: Pharmacoepidemiol Drug Saf. 2019 Feb 12. DOI: 10.1002/pds.4724Additional InformationRelated Assessment(s): Developing Capacity for “Surveillance of Prescribing Behaviors” Analyses in Sentinel, with Dronedarone and ECGs as a Use CaseContributorsAuthor(s): Noelle M. Cocoros, Anita Wagner, Kevin Haynes, Andrew B. Petrone, Elnara Fazio‐Eynullayeva, Yulan Ding, Rima Izem, Joo‐Yeon Lee, Jacqueline M. Major, Michael Nguyen, Jing JuCorresponding Author: Noelle M. Cocoros, Department of Population Medicine, Harvard Medical School and the Harvard Pilgrim Health Care Institute, Boston, MA, USA. Email: noelle_cocoros@harvardpilgrim.org
